Oculis Pharma (private company)

See something wrong or missing? Let us know
Offices:Reykjavik
Industry:Pharma
Business model:B2B

Oculis is a clinical-stage, privately held, pharmaceutical development company focusing on ophthalmic drugs and novel drug delivery to the eye.
Oculis has developed a drug delivery platform consisting of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application, i.e. an eye drop.

Investors: we tracked 11 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 193.02M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Oculis Pharma

Name Criteria
Italy 1000Farmacie
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Beckley Psytech
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 7
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Spain Bigfinite
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Finland Desentum
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Spain Ona Therapeutics
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 7
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Qualifyze
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 6
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Top